Donor eligibility criteria and liver graft acceptance criteria during normothermic regional perfusion: A systematic review

Ivo J. Schurink, Fenna E. M. Leemkolk, Constantino Fondevila, Riccardo De Carlis, Eric Savier, Gabriel C. Oniscu, Volkert A. L. Huurman, Jeroen Jonge – 22 May 2022 – Acceptance of liver grafts from donations after circulatory death (DCD) largely remains a “black box,” particularly due to the unpredictability of the agonal phase. Abdominal normothermic regional perfusion (aNRP) can reverse ischemic injury early during the procurement procedure, and it simultaneously enables graft viability testing to unravel this black box.

The impact of human leukocyte antigen mismatch on recipient outcomes in living‐donor liver transplantation

Tetsuya Tajima, Koichiro Hata, Jiro Kusakabe, Hidetaka Miyauchi, Kimiko Yurugi, Rie Hishida, Eri Ogawa, Tatsuya Okamoto, Mari Sonoda, Shoichi Kageyama, Xiangdong Zhao, Takashi Ito, Satoru Seo, Hideaki Okajima, Miki Nagao, Hironori Haga, Shinji Uemoto, Etsuro Hatano – 22 May 2022 – Donor–recipient human leukocyte antigen (HLA) compatibility has not been considered to significantly affect liver transplantation (LT) outcomes; however, its significance in living‐donor LT (LDLT), which is mostly performed between blood relatives, remains unclear.

Subscribe to